Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.79 |
| ▸ | THRB | P10828 | 2/20 | 0.65 |
| ▸ | CES2 | O00748 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL874759 | 1.00 | TSHR (0.79) | TSHRTHRBCES2HTTMEN1 | |
| SCHEMBL19077762 | 1.00 | TSHR (0.79) | TSHRTHRBCES2HTTMEN1 | |
| SCHEMBL11114441 | 1.00 | TSHR (0.79) | TSHRTHRBCES2HTTMEN1 | |
| SCHEMBL19077763 | 1.00 | TSHR (0.79) | TSHRTHRBCES2HTTMEN1 | |
| SCHEMBL5454703 | 1.00 | TSHR (0.79) | TSHRTHRBCES2HTTMEN1 | |
| SCHEMBL19077765 | 1.00 | TSHR (0.79) | TSHRTHRBCES2HTTMEN1 | |
| SCHEMBL5455892 | 1.00 | TSHR (0.79) | TSHRTHRBCES2HTTMEN1 | |
| SCHEMBL874556 | 1.00 | TSHR (0.79) | TSHRTHRBCES2HTTMEN1 | |
| SCHEMBL2997982 | 1.00 | TSHR (0.79) | TSHRTHRBCES2HTTMEN1 | |
| SCHEMBL7641931 | 1.00 | TSHR (0.79) | TSHRTHRBCES2HTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115243767-B | Oil-in-water type emulsified cosmetic | 花王株式会社 | 2024-07-16 | — | — | CN | claimed |
| EP-3554470-B1 | COSMETIC COMPOSITIONS COMPRISING HYALURONIC ACID | ELC MAN LLC (US) | 2023-07-26 | — | — | EP | claimed |
| US-20230125112-A1 | OIL-IN-WATER-TYPE EMULSIFIED COSMETIC MATERIAL | KAO CORPORATION (JP) | 2023-04-27 | — | — | US | claimed |
| EP-4115952-A1 | OIL-IN-WATER-TYPE EMULSIFIED COSMETIC MATERIAL | Kao Corporation (JP) | 2023-01-11 | — | — | EP | claimed |
| US-12458613-B2 | Methods suitable for the treatment of acne | KENVUE BRANDS LLC (US) | 2025-11-04 | — | — | US | disclosed |
| WO-2025127116-A1 | AQUEOUS COMPOSITION FOR BODY | 花王株式会社 | 2025-06-19 | — | — | WO | disclosed |
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | Ananda Scientific, Inc. (US) | 2025-06-19 | — | — | US | disclosed |
| US-20250152484-A1 | OIL-IN-WATER EMULSION SKIN PREPARATION FOR EXTERNAL USE | KAO CORPORATION (JP) | 2025-05-15 | — | — | US | disclosed |
| US-20250032469-A1 | TOPICAL COMPOSITION FOR ADMINISTRATION TO NAILS | MIM PHARMA GMBH (DE) | 2025-01-30 | — | — | US | disclosed |
| CN-114980858-B | Oil-in-water type emulsified cosmetic | 株式会社资生堂 | 2024-12-06 | — | — | CN | disclosed |
| EP-4470629-A1 | OIL-IN-WATER EMULSION SKIN PREPARATION FOR EXTERNAL USE | Kao Corporation (JP) | 2024-12-04 | — | — | EP | disclosed |
| EP-4470526-A2 | TOPICAL COMPOSITION FOR ADMINISTRATION TO NAILS | MiM Pharma GmbH (DE) | 2024-12-04 | — | — | EP | disclosed |
| US-11324676-B2 | Hydrogen peroxide formulations in barrier layer films with a metalized layer | HENKEL AG & CO. KGAA (DE) | 2022-05-10 | — | — | US | disclosed |
| US-11311472-B2 | Topical composition comprising crosslinked hyaluronic acid and a polyacrylate compound | TEOXANE (CH) | 2022-04-26 | — | — | US | disclosed |
| US-11291286-B2 | Cosmetic compositions with a micro-mesh structure | ELC MANAGEMENT LLC (US) | 2022-04-05 | — | — | US | disclosed |
| US-20220047543-A1 | METHODS AND COMPOSITIONS SUITABLE FOR THE TREATMENT OF ACNE | KENVUE BRANDS LLC | 2022-02-17 | — | — | US | disclosed |
| US-20220047536-A1 | METHODS SUITABLE FOR DISRUPTING A BIOFILM, AND/OR KILLING BACTERIA CONTAINED IN A BIOFILM | KENVUE BRANDS LLC | 2022-02-17 | — | — | US | disclosed |
| US-9417522-B2 | Photosensitive resin composition and method for producing resist pattern | JSR CORPORATION (JP) | 2016-08-16 | — | — | US | disclosed |
| US-20150185604-A1 | PHOTOSENSITIVE RESIN COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | JSR CORPORATION (JP) | 2015-07-02 | — | — | US | disclosed |
| US-20070231747-A1 | Radiation-sensitive negative resin composition | JSR CORPORATION (JP) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220047543-A1 | METHODS AND COMPOSITIONS SUITABLE FOR THE TREATMENT OF ACNE | LGALS7; LGALS7B, MGAT3, ALG1 | TSHR 3481/4885THRB 2358/4885CES2 3635/4885 |
| US-20220047536-A1 | METHODS SUITABLE FOR DISRUPTING A BIOFILM, AND/OR KILLING BACTERIA CONTAINED IN A BIOFILM | HAO2, CUTA, HACL2 | TSHR 2374/4885THRB 565/4885CES2 1151/4885 |
| US-12458613-B2 | Methods suitable for the treatment of acne | CUTA, HSD17B12, HAO2 | TSHR 1992/4885THRB 618/4885CES2 860/4885 |
| US-11291286-B2 | Cosmetic compositions with a micro-mesh structure | CD44, CUTA, MSH6 | TSHR 2549/4885THRB 3210/4885CES2 3573/4885 |
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | CNR2, CNR1, FAAH | TSHR 3371/4885THRB 4002/4885CES2 158/4885 |
| US-11311472-B2 | Topical composition comprising crosslinked hyaluronic acid and a polyacrylate compound | CUTA, CD44, COL14A1 | TSHR 4632/4885THRB 4386/4885CES2 512/4885 |
| US-20250152484-A1 | OIL-IN-WATER EMULSION SKIN PREPARATION FOR EXTERNAL USE | CUTA, NAPEPLD, LIPA | TSHR 4317/4885THRB 4288/4885CES2 1150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.